Volitionrx (VNRX) EPS (Basic) Growth (5y) (2016 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Volitionrx | 101.83 Mn | 99.36 Mn | -1.01 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 15.61% |
| Sep 30, 2025 | 62.64% |
| Jun 30, 2025 | 14.93% |
| Mar 31, 2025 | -1.68% |
| Dec 31, 2024 | -22.89% |
| Sep 30, 2024 | 7.91% |
| Jun 30, 2024 | 5.14% |
| Mar 31, 2024 | 3.18% |
| Dec 31, 2023 | -146.86% |
| Sep 30, 2023 | 5.22% |
| Jun 30, 2023 | 1.15% |
| Mar 31, 2023 | 3.01% |
| Dec 31, 2022 | 25.90% |
| Sep 30, 2022 | 14.96% |
| Jun 30, 2022 | 15.00% |
| Mar 31, 2022 | 15.01% |
| Dec 31, 2021 | -4.56% |
| Sep 30, 2021 | 2.82% |
| Jun 30, 2021 | 5.11% |
| Mar 31, 2021 | 1.59% |
| Dec 31, 2020 | 6.01% |
| Sep 30, 2020 | 10.87% |
| Jun 30, 2020 | -3.71% |
| Mar 31, 2020 | -3.13% |
| Dec 31, 2019 | -9.86% |
| Sep 30, 2019 | 25.65% |
| Jun 30, 2019 | -30.83% |
| Mar 31, 2019 | 7.79% |
| Dec 31, 2018 | -9.46% |
| Sep 30, 2018 | -11.84% |
| Jun 30, 2018 | -8.45% |
| Mar 31, 2018 | -13.56% |
| Dec 31, 2017 | 1.28% |
| Sep 30, 2017 | -10.76% |
| Jun 30, 2017 | -5.39% |
| Mar 31, 2017 | -7.63% |
| Dec 31, 2016 | -1.76% |
| Sep 30, 2016 | -4.56% |
| Jun 30, 2016 | 0.00% |
| Mar 31, 2016 | -10.20% |